These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37400884)

  • 21. Audit and feedback as a tool to increase compliance with carbapenemase-producing Enterobacteriaceae (CPE) screening and decrease CPE transmission in the hospital.
    Ben Natan O; Stein M; Reisfeld S
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1788-1792. PubMed ID: 36081188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of contact isolation strategy for the containment of extended-spectrum β-lactamase carriers in a University Hospital positively affects the epidemiology of carbapenemase-producing Enterobacterales.
    Hernández-García M; Díaz-Agero C; Pérez-Viso B; Sánchez AM; López-Fresneña N; Morosini MI; Ruiz-Garbajosa P; Cantón R
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Nov; 39(9):429-435. PubMed ID: 34736747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction.
    Lowman W; Marais M; Ahmed K; Marcus L
    J Hosp Infect; 2014 Oct; 88(2):66-71. PubMed ID: 25082751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
    Otter JA; Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD
    J Antimicrob Chemother; 2016 Dec; 71(12):3556-3561. PubMed ID: 27516471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving epidemiology of carbapenemase-producing Enterobacterales: one hospital's infection prevention and control response over nine years.
    Foley M; Duffy F; Skally M; McCormack F; Finn C; O'Connor M; Cafferkey J; Thomas T; Burns K; Fitzpatrick F; O'Connell K; Smyth EG; Humphreys H
    J Hosp Infect; 2021 Jun; 112():61-68. PubMed ID: 33812939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An optimized algorithm with improved turnaround time for detection of carbapenemase-producing
    Ratnayake L; Ang HZ; Ong CH; Chan DSG
    J Med Microbiol; 2020 Feb; 69(2):228-232. PubMed ID: 31922949
    [No Abstract]   [Full Text] [Related]  

  • 27. A practical approach to screening for carbapenemase-producing Enterobacterales- views of a group of multidisciplinary experts from English hospitals.
    Jenkins DR; Auckland C; Chadwick C; Dodgson AR; Enoch DA; Goldenberg SD; Hussain A; Martin J; Spooner E; Whalley T
    BMC Infect Dis; 2024 Apr; 24(1):444. PubMed ID: 38671365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial impact of a national programme to contain the spread of carbapenemase-producing Enterobacterales in Ireland.
    Vellinga A; Brennan W; Humphreys H; Burns K
    J Hosp Infect; 2021 Mar; 109():107-114. PubMed ID: 33429000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of the Xpert Carba-R assay for active surveillance of rectal carbapenemase-producing organisms in intensive care unit patients.
    Ko YJ; Kim J; Kim HN; Yoon SY; Lim CS; Lee CK
    Antimicrob Resist Infect Control; 2019; 8():127. PubMed ID: 31384432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.
    Tinelli M; Rossini A; Scudeller L; Zabzuni D; Errico G; Fogato E; D'Angelo R; Gentiloni Silverj F; Cesana E; Bergamaschini LC; Pasi F; Monaco M; Cerquetti M; Pantosti A; Giufrè M
    Int J Antimicrob Agents; 2022 Jun; 59(6):106594. PubMed ID: 35483624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections.
    Smolders D; Hendriks B; Rogiers P; Mul M; Gordts B
    J Hosp Infect; 2019 May; 102(1):82-88. PubMed ID: 30579969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and Transmission of Carbapenemase-Producing
    Aung AH; Kanagasabai K; Koh J; Hon PY; Ang B; Lye D; Chen SL; Chow A
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0258420. PubMed ID: 34001509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model.
    Harris HC; Buckley AM; Spittal W; Ewin D; Clark E; Altringham J; Bentley K; Moura IB; Wilcox MH; Woodford N; Davies K; Chilton CH
    J Hosp Infect; 2021 Jul; 113():1-9. PubMed ID: 33932556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of hospital sewage shows both promise and limitations as an early-warning system for carbapenemase-producing Enterobacterales in a low-prevalence setting.
    Flach CF; Hutinel M; Razavi M; Åhrén C; Larsson DGJ
    Water Res; 2021 Jul; 200():117261. PubMed ID: 34082263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
    Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
    Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    Trepanier P; Mallard K; Meunier D; Pike R; Brown D; Ashby JP; Donaldson H; Awad-El-Kariem FM; Balakrishnan I; Cubbon M; Chadwick PR; Doughton M; Doughton R; Hardiman F; Harvey G; Horner C; Lee J; Lewis J; Loughrey A; Manuel R; Parsons H; Perry JD; Vanstone G; White G; Shetty N; Coia J; Wiuff C; Hopkins KL; Woodford N
    J Antimicrob Chemother; 2017 Feb; 72(2):596-603. PubMed ID: 27687074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Xpert® Carba-R on enrichment broth for the early detection of carbapenemase-producing Enterobacterales.
    Girlich D; Ouzani S; Langlois I; Fortineau N; Naas T; Dortet L
    Int J Infect Dis; 2021 Nov; 112():183-185. PubMed ID: 34547497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a novel procedure for rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) using the LightMix® modular carbapenemase kits.
    Oviaño M; Torres I; González M; Bou G
    J Antimicrob Chemother; 2016 Dec; 71(12):3420-3423. PubMed ID: 27566313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014-2016.
    Pirš M; Cerar Kišek T; Križan Hergouth V; Seme K; Mueller Premru M; Jeverica S; Logar M; Mrvič T; Žnidaršič B; Jordan Markočič O; Lejko Zupanc T
    J Hosp Infect; 2019 Feb; 101(2):142-149. PubMed ID: 30399389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.